A genomewide association study on susceptibility to HCV in HIV-1+ MSM

  • Research type

    Research Study

  • Full title

    A genomewide association study (GWAS) on susceptibility to sexual transmission of Hepatitis C virus (HCV) among HIV-1+ MSM

  • IRAS ID

    226236

  • Contact name

    Katrina Stegmann

  • Contact email

    katrina.stegmann@chelwest.nhs.uk

  • Sponsor organisation

    Amsterdam Medical Centre

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    Rationale:
    Despite high-risk behavior for hepatitis C (HCV) transmission and substantial prevalence in the population, some individuals remain uninfected, suggesting that host factors play a role in HCV susceptibility. To determine whether genetic factors play a role in HCV susceptibility we want to perform a genome wide association study (GWAS) on individuals at high risk for acquiring HCV, to identify single nucleotide polymorphisms (SNPs) in host genes.

    Objective:
    To identify genetic host factors associated with HCV susceptibility among HIV-infected MSM.

    Study design:
    This is a case-control study to be carried out at multiple HIV-treatment clinics in Amsterdam as well as HIV-treatment clinics in Berlin (Zentrum für Infektiologie, Berlin Prenzlauer Berg, Dr. P. Ingiliz) and New York (Mount Sinai Hospital and the Callen-Lorde Clinic, Dr. D. Fierer) and London (Chelsea and Westminster Hospital, Prof. M. Nelson). It is an observational study without invasive measurements. Participants will be requested to fill out a questionnaire allowing assessment of risk behaviour which facilitates HCV transmission. A buccal swab will be collected from each participant. DNA derived from the buccal swabs from cases and high-risk controls (i.e. a selection of all controls that are included) will be analysed using an Illumina ‘Global Screening Array’, enabling genotyping of 700.000 single nucleotide polymorphisms (SNPs).

    Study population:
    HIV-infected men who have sex with men (MSM), 18+ yr old. Controls are HIV-infected MSM without (past) HCV infection. Cases are HIV-infected MSM with current or past HCV infection.

    Main study parameters/endpoints:
    Identification of SNPs associated with HCV susceptibility

  • REC name

    HSC REC A

  • REC reference

    17/NI/0111

  • Date of REC Opinion

    21 Jun 2017

  • REC opinion

    Further Information Favourable Opinion